Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/ RNS generation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mulukutla BC, et al. Regulation of Glucose Metabolism - A Perspective From Cell Bioprocessing. Trends Biotechnol. 2016;34(8):638-51.
McNamara JT, Morgan JL, Zimmer J. A molecular description of cellulose biosynthesis. Annu Rev Biochem. 2015;84:895–921.
Berchtold NC, Cotman CW. Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-roman period to the 1960s. Neurobiol Aging. 1998;19(3):173–89.
Münch G, et al. Alzheimer's Disease–synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm. 1998;105(4-5):439–61.
Hofman A, et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30(8):661-708. PMID:26386597; PMCID:PMC4579264. doi: 10.1007/s10654-015-0082-x .
Ahmad W. Overlapped metabolic and therapeutic links between Alzheimer and diabetes. Mol Neurobiol. 2013;47(1):399–424.
Mittal K, Katare DP. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S144-9.
Rosales-Corral S, et al. Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress. Oxidative Med Cell Longev. 2015;2015:985845.
Takeuchi M, Yamagishi S-i. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Curr Pharm Des. 2008;14(10):973–8.
Biessels G, Kappelle L. Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans. 2005;33(5):1041–4.
Butterfield DA, Di Domenico F, Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta. 2014;1842(9):1693–706.
Montecalvo MA, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1995;16(12):680–5.
Reser JE. Alzheimer's Disease and natural cognitive aging may represent adaptive metabolism reduction programs. Behav Brain Funct. 2009;5(1):1.
Wang J, Yang X, Zhang J. Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic beta cells. Cell Signal. 2016;28(8):1099–104.
Sadeghi A, et al. The effect of diabetes mellitus on apoptosis in hippocampus: cellular and molecular aspects. Int J Prev Med. 2016;7:57.
Zheng H, et al. Protein modifications as manifestations of hyperglycemic Glucotoxicity in diabetes and its complications. Biochem Insights. 2016;9:1–9.
Ceriello A, Testa R, Genovese S. Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications. Nutr Metab Cardiovasc Dis. 2016;26(4):285–92.
Tramutola A, et al. Oxidative stress, protein modification and Alzheimer disease. Brain Res Bull. 2017;133:88-96.
Grimm A, Mensah-Nyagan AG, Eckert A. Alzheimer, mitochondria and gender. Neurosci Biobehav Rev. 2016;67:89-101.
Cervellati C, et al. Oxidative challenge in Alzheimer's disease: state of knowledge and future needs. J Investig Med. 2016;64(1):21–32.
Commoner B, Townsend J, Pake GE. Free radicals in biological materials. Nature. 1954;174(4432):689–91.
Newsholme P, et al. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473(24):4527–50.
Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239–47.
Gracy R, et al. Reactive oxygen species: the unavoidable environmental insult? Mutat Res Fundam Mol Mech Mutagen. 1999;428(1):17–22.
Bansal AK, Bilaspuri G. Impacts of oxidative stress and antioxidants on semen functions. Vet Med Int. 2010;2011
Halliwell B, Gutteridge J. Biologically relevant metal ion-dependent hydroxyl radical generation an update. FEBS Lett. 1992;307(1):108–12.
Kohen R, Gati I. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology. 2000;148(2):149–57.
Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem. 2015;30(1);11-26.
Kohen R, Moor E, Oron M. Measurements of biological reducing power in health and diseases by voltammetric methods. Redox Genome Interaction Health Dis. 2004:13–42.
Koren HS. Associations between criteria air pollutants and asthma. Environ Health Perspect. 1995;103(Suppl 6):235.
Chinev S, et al. Lipid peroxidation in rat lung induced by neuroleptanalgesia and its components. Eur J Anaesthesiol. 1998;15(6):686–94.
Sen C, Packer L, Hänninen O. Biological thiols and redox regulation of cellular signal transduction pathways. Handbook of oxidants and antioxidants in exercise. Amsterdam: Elsevier; 2000. p. 375–402.
Shadyro O, Yurkova I, Kisel M. Radiation-induced peroxidation and fragmentation of lipids in a model membrane. Int J Radiat Biol. 2002;78(3):211–7.
Elsayed NM, et al. Free radical-mediated lung response to the monofunctional sulfur mustard butyl 2-chloroethyl sulfide after subcutaneous injection. Toxicology. 1992;72(2):153–65.
Obata T, et al. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP+) into the striatum is associated with hydroxyl free radical generation. Brain Res. 2001;906(1):170–5.
Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18(6):655–73.
Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002;166(supplement_1):S4–8.
Fleury C, Mignotte B, Vayssière J-L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84(2):131–41.
Gutteridge JM, Halliwell B. Invited review free radicals in disease processes: a compilation of cause and consequence. Free Radic Res Commun. 1993;19(3):141–58.
Dong J, et al. Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence. Biochemistry. 2003;42(10):2768–73.
Hoyer S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol. 2004;541:135-52.
Butterfield DA, Pocernich CB. The glutamatergic system and Alzheimer’s disease. CNS drugs. 2003;17(9):641–52.
Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001;410(6831):988–94.
Bielski BH, et al. Reactivity of HO2/O− 2 radicals in aqueous solution. J Phys Chem Ref Data. 1985;14(4):1041–100.
Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30(11):1191–212.
Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30(6):620-50.
Hrbac J, Kohen R. Biological redox activity: its importance, methods for its quantification and implication for health and disease. Drug Dev Res. 2000;50(3-4):516–27.
Priora R, et al. Measurement of mixed disulfides including glutathionylated proteins. Methods Enzymol. 2010;473:149–59.
Muralidharan P, et al. Evidence for redox sensing by a human cardiac calcium channel. Sci Rep. 2016;6
Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47–95.
Newsholme P, et al. Nutrient regulation of insulin secretion and action. J Endocrinol. 2014;221(3):R105–20.
Salsali A, Nathan M. A review of types 1 and 2 diabetes mellitus and their treatment with insulin. Am J Ther. 2006;13(4):349-61.
Wallace T, Matthews D. Recent advances in the monitoring and management of diabetic ketoacidosis. QJM. 2004;97(12):773–80.
Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—a concise review. Saudi Pharm J. 2016;24(5):547–53.
Loghmani E. Diabetes mellitus: type 1 and type 2. Guidelines for adolescent nutrition services; 2005. p. 167–82.
Kangralkar V, Patil SD, Bandivadekar R. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38–45.
Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4(2):89–96.
Maritim A, Sanders a, Watkins r J. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.
Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complicat. 2001;15(4):203–10.
Moussa S. Oxidative stress in diabetes mellitus. Romanian J Biophys. 2008;18(3):225–36.
Erejuwa OO. Oxidative stress in diabetes mellitus: is there a role for hypoglycemic drugs and/or antioxidants. Oxidative stress and diseases; 2012. p. 217–46.
Ceriello PA. Oxidative stress and diabetes-associated complications. Endocr Pract. 2006;12(Supplement 1):60–2.
Calkins MJ, Manczak M, Reddy PH. Mitochondria-targeted antioxidant SS31 prevents amyloid beta-induced mitochondrial abnormalities and synaptic degeneration in Alzheimer’s disease. Pharmaceuticals. 2012;5(10):1103–19.
Jahangir Z, Ahmad W, Shabbiri K. Alternate Phosphorylation/O-GlcNAc modification on human insulin IRSs: a road towards impaired insulin signaling in Alzheimer and diabetes. Adv Bioinforma. 2014;2014:324753.
Sorriento D, et al. Targeting mitochondria as therapeutic strategy for metabolic disorders. ScientificWorldJournal. 2014;2014:604685.
Guzik TJ, et al. Vascular superoxide production by NAD (P) H oxidase association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86(9):e85–90.
Ceriello A, et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44(7):834–8.
Guzik TJ, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus role of NAD (P) H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656–62.
Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev. 2010;131(4):276–86.
Jiang Z-Y, Woollard A, Wolff SP. Hydrogen peroxide production during experimental protein glycation. FEBS Lett. 1990;268(1):69–71.
Wolff SP, Dean R. Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’in diabetes. Biochem J. 1987;245(1):243–50.
Halliwell B, Gutteridge JM. [1] Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1–85.
Hogg N, et al. Inhibition of low-density lipoprotein oxidation by nitric oxide potential role in atherogenesis. FEBS Lett. 1993;334(2):170–4.
Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416(1):15–8.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.
Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int. 2000;58:S26–30.
Pacher P, Szabó C. Role of poly (ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal. 2005;7(11-12):1568–80.
Williamson JR, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42(6):801–13.
Choudhury, M., Involvement of Caspase-7 in photoreceptor and retinal ganglion cell death. 2014.
Zhang Z, et al. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem. 2000;275(51):40042–7.
James LR, et al. Flux through the Hexosamine pathway is a determinant of nuclear factor κB–dependent promoter activation. Diabetes. 2002;51(4):1146–56.
Goldberg HJ, Whiteside CI, Fantus IG. The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-βI and-δ. J Biol Chem. 2002;277(37):33833–41.
Du X-L, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci. 2000;97(22):12222–6.
Li L-X, et al. Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal β-cells. Biochem Biophys Res Commun. 2001;282(1):273–7.
Nishikawa T, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787–90.
Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48(1):1–9.
McCarthy A, Etcheverry S, Cortizo A. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol. 2001;38(3):113–22.
Ergul A, et al. Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1. J Pharmacol Exp Ther. 2005;313(1):70–7.
Amiri F, et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int. 2002;61(5):1605–16.
Wake H, et al. Histamine inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes. J Pharmacol Exp Ther. 2009;330(3):826–33.
Takahashi HK, et al. Advanced glycation end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther. 2009;330(1):89–98.
Lohwasser C, et al. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Investig Dermatol. 2006;126(2):291–9.
Hergrueter AH, Nguyen K, Owen CA. Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2011;300(4):L512-5.
Tsai EC, et al. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 1994;43(8):1010–4.
Kawamura M, Heinecke JW, Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Investig. 1994;94(2):771.
Evans JL, et al. Are oxidative stress− activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003;52(1):1–8.
Roth M. The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease. Br Med Bull. 1986;42(1):42–50.
Juhaszova M, et al. Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res. 2005;66(2):233–44.
Tani M, et al. Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res. 2001;49(1):56–68.
Jang YC, et al. Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J. 2010;24(5):1376–90.
Li F-J, Shen L, Ji H-F. Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis. J Alzheimers Dis. 2012;31(2):253–8.
Migliaccio E, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999;402(6759):309–13.
Giorgio M, et al. Electron transfer between cytochrome c and p66 Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;122(2):221–33.
Cha M-Y, et al. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One. 2012;7(4):e34929.
Reddy PH. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol. 2009;218(2):286–92.
Canugovi C, et al. Base excision DNA repair levels in mitochondrial lysates of Alzheimer's disease. Neurobiol Aging. 2014;35(6):1293–300.
Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med. 2013;62:90–101.
Ahmad W, Ebert PR. Metformin Attenuates Abeta Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease. Mol Neurobiol. 2017;54(7):5427-439.
Praticò D, Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer’s disease. Am J Med. 2000;109(7):577–85.
Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Exp Biol Med. 1999;222(3):236–45.
Zhu X, et al. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta. 2007;1772(4):494–502.
Wang X, et al. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci. 2008;105(49):19318–23.
Park KW, Baik HH, Jin BK. IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo. J Immunol. 2009;183(7):4666–74.
Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40(4):405–12.
Hazel JR, Williams EE. The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment. Prog Lipid Res. 1990;29(3):167–227.
Prasad MR, et al. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res. 1998;23(1):81–8.
Roberts LJ, Morrow JD. Measurement of F 2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28(4):505–13.
Stadtman ER. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med. 1990;9(4):315–25.
Smith MA, et al. Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci. 1997;17(8):2653–7.
Good PF, et al. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol. 1996;149(1):21.
Moreira PI, et al. Alzheimer's Disease and oxidative stress: the old problem remains unsolved. Curr Med Chem Cent Nerv Syst Agents. 2005;5(1):51–62.
Aksenov M, et al. Protein oxidation in the brain in Alzheimer's disease. Neuroscience. 2001;103(2):373–83.
Bubber P, et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol. 2005;57(5):695–703.
Cao X, et al. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci. 2006;29:77–103.
Mehler MF, Mattick JS. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev. 2007;87(3):799–823.
Nunomura A, et al. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol. 2009;118(1):151–66.
Zhu X, et al. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Alzheimer's Dis. 2013;33(0 1):S253.
Zaid H, et al. The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ. 2005;12(7):751–60.
Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol. 2001;3(11):E255–63.
Pereira C, et al. Cell degeneration induced by amyloid-β peptides. J Mol Neurosci. 2004;23(1-2):97–104.
Sergeant N, et al. Association of ATP synthase α-chain with neurofibrillary degeneration in Alzheimer’s disease. Neuroscience. 2003;117(2):293–303.
Poon SR, B-K D, Klein JB, Merchant M, Markesbery WR, Butterfield DA. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging. 2006;27:1564–76.
Yan L-J. Positive oxidative stress in aging and aging-related disease tolerance. Redox Biol. 2014;2:165–9.
Akter K, et al. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol. 2011;71(3):365–76.
Bomfim TR, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers. J Clin Invest. 2012;122(4):1339–53.